Detalhe da pesquisa
1.
The impact of genomic context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review.
Ann Oncol;
34(12): 1113-1130, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37875224
2.
A state-of-the-art review of stratified medicine in cancer: towards a future precision medicine strategy in cancer.
Ann Oncol;
33(2): 143-157, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34808340
3.
Mechanisms of immunogenicity in colorectal cancer.
Br J Surg;
106(10): 1283-1297, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31216061
4.
Supervised exercise training as an adjunct therapy for venous leg ulcers: a randomized controlled feasibility trial.
Br J Dermatol;
178(5): 1072-1082, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29077990
5.
Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials.
Ann Oncol;
28(3): 562-568, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27993800
6.
Consensus on precision medicine for metastatic cancers: a report from the MAP conference.
Ann Oncol;
27(8): 1443-8, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27143638
7.
Brief Report: Implementing a Mediterranean Diet Intervention into a RCT: Lessons Learned from a Non-Mediterranean Based Country.
J Nutr Health Aging;
19(10): 1019-22, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26624214
8.
The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer.
Ann Oncol;
26(12): 2464-9, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26410619
9.
Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study.
Ann Oncol;
26(1): 149-156, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25416687
10.
Time to adjuvant chemotherapy following colorectal cancer resection is associated with an improved survival.
Colorectal Dis;
16(5): 368-72, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24456198
11.
Implementing a community-based obesity prevention programme: experiences of stakeholders in the north east of England.
Health Promot Int;
29(2): 201-11, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23297339
12.
Evaluation of serum lysyl oxidase as a blood test for colorectal cancer.
Eur J Surg Oncol;
40(6): 731-8, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24246612
13.
A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer.
Lung Cancer;
82(2): 276-81, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23992877
14.
Biomarker analysis in oesophagogastric cancer: Results from the REAL3 and TransMAGIC trials.
Eur J Cancer;
49(9): 2116-25, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23481512
15.
Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report.
Ann Oncol;
24(3): 702-9, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23108952
16.
A qualitative exploration of stakeholder perspectives on a school-based multi-component health promotion nutrition programme.
J Hum Nutr Diet;
25(6): 547-56, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22748036
17.
Magnetic resonance imaging of the ligamentous structures of the occipitoatlantoaxial region in the dog.
Vet Radiol Ultrasound;
53(5): 545-51, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22730919
18.
Current status of GV1001 and other telomerase vaccination strategies in the treatment of cancer.
Expert Rev Vaccines;
9(9): 1007-16, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20822343
19.
Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials.
Br J Cancer;
94(8): 1107-15, 2006 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-16622436
20.
Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with irinotecan monotherapy.
Br J Cancer;
91(8): 1453-8, 2004 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-15365570